ArticleHeliyon2024

Novel insights into post-marketing adverse events associated with lenvatinib: A comprehensive analysis utilizing the FAERS database.

Zhe Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.